KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹18 Cr | ₹-1.53 Cr | ₹2.59 Cr | ₹5.78 Cr | ₹46 Cr |
What is the latest Cash Flow from Operating Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-1.53 Cr |
| Mar2023 | ₹2.59 Cr |
| Mar2022 | ₹5.78 Cr |
| Mar2021 | ₹46 Cr |
How is Cash Flow from Operating Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-1.53 Cr | Negative | |
| Mar2023 | ₹2.59 Cr | -55.28 | |
| Mar2022 | ₹5.78 Cr | -87.33 | |
| Mar2021 | ₹46 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹561.0 Cr | -3.3% | -1.1% | 6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -3.3% |
-1.1% |
6.2% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses